Pallas Capital Advisors LLC lessened its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 3.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 5,564 shares of the electronics maker’s stock after selling 185 shares during the period. Pallas Capital Advisors LLC’s holdings in Dolby Laboratories were worth $413,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Parallel Advisors LLC grew its holdings in shares of Dolby Laboratories by 12.5% in the 2nd quarter. Parallel Advisors LLC now owns 5,659 shares of the electronics maker’s stock valued at $420,000 after buying an additional 630 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its stake in Dolby Laboratories by 36.7% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,902 shares of the electronics maker’s stock worth $141,000 after purchasing an additional 511 shares during the period. Strs Ohio acquired a new position in Dolby Laboratories in the 1st quarter worth $2,012,000. Acadian Asset Management LLC boosted its stake in Dolby Laboratories by 0.6% in the 1st quarter. Acadian Asset Management LLC now owns 1,140,821 shares of the electronics maker’s stock worth $91,602,000 after purchasing an additional 6,953 shares during the period. Finally, Focus Partners Wealth acquired a new position in Dolby Laboratories in the 1st quarter worth $390,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $95.00 target price on shares of Dolby Laboratories in a research note on Friday, August 1st. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price for the company. Tigress Financial increased their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Finally, Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.75.
Dolby Laboratories Price Performance
Shares of NYSE:DLB opened at $71.53 on Friday. The company’s 50 day simple moving average is $73.38 and its 200 day simple moving average is $75.16. The stock has a market capitalization of $6.86 billion, a price-to-earnings ratio of 26.20 and a beta of 0.93. Dolby Laboratories has a 1 year low of $68.24 and a 1 year high of $89.66.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to analysts’ expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories’s payout ratio is presently 48.35%.
Insiders Place Their Bets
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total transaction of $1,791,500.00. Following the sale, the chief executive officer owned 114,725 shares of the company’s stock, valued at approximately $8,221,193.50. The trade was a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of the business’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 124,366 shares of company stock worth $9,144,463. Insiders own 38.39% of the company’s stock.
Dolby Laboratories Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- How to invest in marijuana stocks in 7 steps
- Caterpillar Stock Hits All-Time High—Is There More Room to Run?
- How to Calculate Stock Profit
- Berkshire-Backed Lennar Slides After Weak Q3 Earnings
- A Deeper Look at Bid-Ask Spreads
- Analysts Turn Bullish on Hershey—Is Pepsi the Next Value Play?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.